The MIMICS-2 study is a prospective, multicentre, interventional study designed to evaluate the safety and effectiveness of BioMimics 3... Read more

Seroba’s investee company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing i... Read more

MIMICS-3D is a prospective, multicentre, observational registry to evaluate the BioMimics 3D Self-Expanding Stent System in the treatme... Read more

Veryan Medical has announced the achievement of four significant milestones in its MIMICS clinical programme: (1) The publication of th... Read more

TOP